Clover Health Investments Price to Book Ratio 2020-2024 | CLOV

Historical price to book ratio values for Clover Health Investments (CLOV) over the last 10 years. The current price to book ratio for Clover Health Investments as of May 08, 2025 is 5.56.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Clover Health Investments Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-05-08 3.75 5.54
2024-12-31 3.15 $0.68 4.65
2024-09-30 2.82 $0.68 4.12
2024-06-30 1.23 $0.65 1.88
2024-03-31 0.79 $0.59 1.35
2023-12-31 0.95 $0.59 1.63
2023-09-30 1.08 $0.66 1.63
2023-06-30 0.90 $0.68 1.31
2023-03-31 0.85 $0.67 1.26
2022-12-31 0.93 $0.75 1.25
2022-09-30 1.70 $0.82 2.07
2022-06-30 2.14 $0.89 2.39
2022-03-31 3.55 $1.03 3.43
2021-12-31 3.72 $1.15 3.25
2021-09-30 7.39 $0.98 7.54
2021-06-30 13.15 $0.77 17.05
2021-03-31 7.46 $1.44 5.17
2020-12-31 16.55 $-6.87 -2.41
2020-09-30 12.30 $0.21 59.59
2020-06-30 11.04 $0.21 52.95
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.926B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.774B 53.56
Hims & Hers Health (HIMS) United States $11.630B 121.74
Tempus AI (TEM) United States $10.119B 0.00
Inspire Medical Systems (INSP) United States $4.616B 72.12
IRhythm Technologies (IRTC) United States $4.348B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $1.955B 12.10
Schrodinger (SDGR) United States $1.732B 0.00
Phreesia (PHR) United States $1.434B 0.00
Azenta (AZTA) United States $1.154B 53.74
Omnicell (OMCL) United States $1.154B 20.35
10x Genomics (TXG) United States $1.016B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Butterfly Network (BFLY) United States $0.530B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.381B 850.00
Claritev (CTEV) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.279B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.03
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
P3 Health Partners (PIII) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00